These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12381699)

  • 1. For institutional review boards, decisions can be subjective.
    Reynolds T
    J Natl Cancer Inst; 2002 Oct; 94(20):1518-20. PubMed ID: 12381699
    [No Abstract]   [Full Text] [Related]  

  • 2. Would central review streamline the clinical trials process?
    Reynolds T
    J Natl Cancer Inst; 2002 Oct; 94(20):1519. PubMed ID: 12381700
    [No Abstract]   [Full Text] [Related]  

  • 3. Institutional review boards (IRBs) would have an increased role in international research.
    Maloney DM
    Hum Res Rep; 2002 Oct; 17(10):9. PubMed ID: 12731498
    [No Abstract]   [Full Text] [Related]  

  • 4. Institutional review boards: informed consent and clinical trial ethics.
    Hunter TH
    Drug Inf J; 1982; 16(1-2):56-9. PubMed ID: 10260016
    [No Abstract]   [Full Text] [Related]  

  • 5. Bad science and the role of institutional review boards.
    Silverman WA
    Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1183-4. PubMed ID: 11115298
    [No Abstract]   [Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of institutional review boards.
    Ghersi D; Campbell EG; Pentz R; Cox Macpherson C
    Lancet Oncol; 2004 May; 5(5):325-9. PubMed ID: 15120672
    [No Abstract]   [Full Text] [Related]  

  • 8. Members of research ethics committees accepted a modification of the randomized consent design.
    Schellings R; Kessels AG; Ter Riet G; Kleijnen J; Leffers P; Knottnerus JA; Sturmans F
    J Clin Epidemiol; 2005 Jun; 58(6):589-94. PubMed ID: 15878472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Institutional review boards should require clinical trial registration.
    Levin LA; Palmer JG
    Arch Intern Med; 2007 Aug 13-27; 167(15):1576-80. PubMed ID: 17698679
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA seeks to ease burden on trial review boards.
    Roehr B
    BMJ; 2005 Apr; 330(7494):748. PubMed ID: 15802716
    [No Abstract]   [Full Text] [Related]  

  • 11. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
    Klitzman R
    Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems with Institutional Review Board inconsistency.
    Veatch RM
    JAMA; 1982 Jul; 248(2):179-80. PubMed ID: 7045427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extend the reach of institutional review boards first, then strengthen their depth.
    Spike J
    Am J Bioeth; 2008 Nov; 8(11):11-2. PubMed ID: 19061097
    [No Abstract]   [Full Text] [Related]  

  • 15. Growing pains: central review board project still developing.
    Randal J
    J Natl Cancer Inst; 2003 May; 95(9):636-7. PubMed ID: 12734305
    [No Abstract]   [Full Text] [Related]  

  • 16. Informed consent and approval by institutional review boards in published reports on clinical trials.
    Ruiz-Canela M; Martínez-González MA; Gómez-Gracia E; Fernández-Crehuet J
    N Engl J Med; 1999 Apr; 340(14):1114-5. PubMed ID: 10206829
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA puts restrictions on an institutional review board after secret investigation.
    Tanne JH
    BMJ; 2009 Apr; 338():b1618. PubMed ID: 19380400
    [No Abstract]   [Full Text] [Related]  

  • 18. Do N-of-1 Trials Need IRB Review?
    Cen R; Hussain A; Pak KJ; Mitchell G; Nikles J; Gaudreau S; Bazzano LA; Breault JL
    J Empir Res Hum Res Ethics; 2016 Jul; 11(3):250-5. PubMed ID: 27534588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the burden on many institutional review boards.
    Maloney DM
    Hum Res Rep; 2003 Jun; 18(6):1-2. PubMed ID: 15119341
    [No Abstract]   [Full Text] [Related]  

  • 20. The institutional review board and beyond: future challenges to the ethics of human experimentation.
    Edgar H; Rothman DJ
    Milbank Q; 1995; 73(4):489-506. PubMed ID: 7491097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.